DISCOVER THE FUTURE OF IMMUNOLOGY AND PREVENTION
Guided by science. Driven by innovation. Inspired by your health
BENEFITS
Revolutionary formulas based on the latest scientific discoveries, designed to optimize immunity at the cellular level.
Boosts natural immunity through innovative mechanisms
Reduces inflammation and fine-tunes the immune system’s response
Supports cellular energy and immune system regeneration
Our MISSION
We are dedicated to producing immunologically active avian proteins and conducting advanced research in modern immunology.
IgY is a unique immunoglobulin that plays a key role in avian immunity. It was first described in 1893 by Emil von Klemperer, who demonstrated that hens could transfer passive immunity to their chicks via antitoxin antibodies found in egg yolk. This discovery laid the foundation for natural immunoprophylaxis using egg-derived antibodies.
The term “IgY” was introduced in the 1970s by Leslie and Clem to distinguish it from the mammalian equivalent, IgG. While they serve similar functions, IgY is structurally distinct and offers benefits such as greater stability in the digestive tract and minimal cross-reactivity with human immune components.
TESTIMONIALS
Insights from respected voices in the medical world
“IgY-based formulas developed here signal the future of personalized and sustainable medicine.”
“Active Immunity provides a much-needed alternative to antibiotics, relevant both in prevention and treatment.”
Key Differentiators
Our formulas are based on the latest scientific discoveries and are designed to strengthen immunity at the cellular level. Backed by research, they offer a natural and effective alternative to conventional immune support.
Natural Origin
Egg-derived IgY as an ethical and sustainable source of immunotherapy
High Specificity
Precisely targets pathogens while preserving the beneficial microbiome
Scalable Production
Efficient processes ready to meet global demand
Let’s Innovate Health Together
Active Immunity represents the future of health and prevention.
Through our advanced proprietary technologies and highly personalised solutions, we offer an unparalleled opportunity for investors and production partners to become part of a global revolution transforming the field of immunology.
Our commitment to measurable health impact, rigorous sustainability practices, and an adaptable, future-focused approach positions Active Immunity as an invaluable partner for those who aspire to lead meaningful change in healthcare. By collaborating with us, you join a mission-driven company dedicated to improving lives on a global scale while unlocking significant growth potential in a rapidly expanding market.
Together, we can advance pioneering solutions that combine scientific excellence with commercial viability, ensuring that every investment contributes not only to financial success but also to a healthier, more sustainable future for all.
